News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Daily News Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients Todd Neale December 14, 2021
News Daily News Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF L.A. McKeown December 07, 2021
News Daily News Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim Caitlin E. Cox November 24, 2021
News Daily News Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends Shelley Wood November 01, 2021
News Daily News As Amyloidosis Field Explodes, Physicians Need to Spot and Treat Todd Neale October 20, 2021
News Daily News VALVENOR Study Helps Clarify Risks in Moderate AS Patients L.A. McKeown October 01, 2021
News Daily News Big Impact Anticipated With HFpEF Expansion of Sacubitril/Valsartan Label Todd Neale September 20, 2021
News Daily News HFSA 2021 In HF and Diabetes, Mobile Health App Modestly Boosts Physical Activity Michael O'Riordan September 15, 2021
News Daily News From Excess Amputations to Postpregnancy HF, Studies Shine Light on Racial Divide L.A. McKeown September 06, 2021
News Daily News FDA Green-lights Empagliflozin for HF With Reduced Ejection Fraction Michael O'Riordan August 19, 2021
News Daily News Getting More Women in CV Research Will ‘Take a Village’ Yael L. Maxwell August 09, 2021
News Daily News Studies Explore Post-MI Use of Beta-blockers, Mineralocorticoid Receptor Antagonists Todd Neale July 09, 2021
News Daily News Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results Todd Neale July 06, 2021
News Daily News Periprocedural MIs Associated With PCI Prognostically Relevant: ESC/EAPCI Michael O'Riordan June 10, 2021
News Daily News Moderate Aortic Stenosis and HFrEF Combo Portends Poor Survival, Study Finds L.A. McKeown June 03, 2021
News Daily News Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care Shelley Wood May 27, 2021